Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline

Mariano Sanz, David Herrera, Moritz Kebschull, Iain Chapple, Søren Jepsen, Tord Beglundh, Anton Sculean, Maurizio S. Tonetti, Anne Merete Aass, Mario Aimetti, Bahar Eren Kuru, Georgios Belibasakis, Juan Blanco, Ellen Bol-van den Hil, Nagihan Bostanci, Darko Bozic, Philippe Bouchard, Nurcan Buduneli, Francesco Cairo, Elena CalciolariMaria Clotilde Carra, Pierpaolo Cortellini, Jan Cosyn, Francesco D'Aiuto, Bettina Dannewitz, Monique Danser, Korkud Demirel, Jan Derks, Massimo de Sanctis, Thomas Dietrich, Christof Dörfer, Henrik Dommisch, Nikos Donos, Kenneth Eaton, Peter Eickholz, Elena Figuero, William Giannobile, Moshe Goldstein, Filippo Graziani, Phophi Kamposiora, Lise Lotte Kirkevang, Thomas Kocher, Eija Kononen, Nicklaus Lang, France Lambert, Luca Landi, Paulo Melo, Bruno Loos, Rodrigo Lopez, Pernilla Lundberg, Eli Machtei, Phoebus Madianos, Conchita Martín, Paula Matesanz, Jörg Meyle, Ana Molina, Eduardo Montero, Jose Nart, Ian Needleman, Luigi Nibali, Panos Papapanou, Andrea Pilloni, David Polak, Ioannis Polyzois, Philip Preshaw, Marc Quirynen, Christoph Ramseier, Stefan Renvert, Giovanni Salvi, Ignacio Sanz-Sánchez, Lior Shapira, Dagmar Else Slot, Andreas Stavropoulos, Xavier Struillou, Jean Suvan, Wim Teughels, Daniela Timus, Cristiano Tomasi, Leonardo Trombelli, Fridus van der Weijden, Paula Vassallo, Clemens Walter, Nicola West, Gernot Wimmer, Ina Kopp, Paul Brocklehurst, Jan Wennström

Producción científicarevisión exhaustiva

852 Citas (Scopus)

Resumen

Background: The recently introduced 2017 World Workshop on the classification of periodontitis, incorporating stages and grades of disease, aims to link disease classification with approaches to prevention and treatment, as it describes not only disease severity and extent but also the degree of complexity and an individual's risk. There is, therefore, a need for evidence-based clinical guidelines providing recommendations to treat periodontitis. Aim: The objective of the current project was to develop a S3 Level Clinical Practice Guideline (CPG) for the treatment of Stage I–III periodontitis. Material and Methods: This S3 CPG was developed under the auspices of the European Federation of Periodontology (EFP), following the methodological guidance of the Association of Scientific Medical Societies in Germany and the Grading of Recommendations Assessment, Development and Evaluation (GRADE). The rigorous and transparent process included synthesis of relevant research in 15 specifically commissioned systematic reviews, evaluation of the quality and strength of evidence, the formulation of specific recommendations and consensus, on those recommendations, by leading experts and a broad base of stakeholders. Results: The S3 CPG approaches the treatment of periodontitis (stages I, II and III) using a pre-established stepwise approach to therapy that, depending on the disease stage, should be incremental, each including different interventions. Consensus was achieved on recommendations covering different interventions, aimed at (a) behavioural changes, supragingival biofilm, gingival inflammation and risk factor control; (b) supra- and sub-gingival instrumentation, with and without adjunctive therapies; (c) different types of periodontal surgical interventions; and (d) the necessary supportive periodontal care to extend benefits over time. Conclusion: This S3 guideline informs clinical practice, health systems, policymakers and, indirectly, the public on the available and most effective modalities to treat periodontitis and to maintain a healthy dentition for a lifetime, according to the available evidence at the time of publication.

Idioma originalEnglish
Páginas (desde-hasta)4-60
Número de páginas57
PublicaciónJournal of Clinical Periodontology
Volumen47
N.ºS22
DOI
EstadoPublished - jul. 1 2020

Financiación

FinanciadoresNúmero del financiador
Botiss Biomaterials
Council of European Dentists
Dexcel Pharma
European Association of Dental Public Health
European Dental Hygienists' Federation
European Prosthodontic Association
European Society for Endodontology
Geistlich Pharma
Klockner Implants, Procter & Gamble and Straumann
Nobel Biocare, Procter & Gamble, Straumann and Sunstar
Oral Reconstruction Foundation
Procter & Gamble, Straumann AG
Sunstar SA
GlaxoSmithKline
Johnson and Johnson
Unilever
Osteology Foundation
European Federation of Conservative Dentistry
ITI Foundation

    ASJC Scopus Subject Areas

    • Periodontics

    Huella

    Profundice en los temas de investigación de 'Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline'. En conjunto forman una huella única.

    Citar esto